130 related articles for article (PubMed ID: 24247436)
1. Oral contraceptives, ABO blood types and thromboembolism.
Ambrus JL
CMAJ; 2013 Nov; 185(17):1526. PubMed ID: 24247436
[No Abstract] [Full Text] [Related]
2. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type.
Sode BF; Allin KH; Dahl M; Gyntelberg F; Nordestgaard BG
CMAJ; 2013 Mar; 185(5):E229-37. PubMed ID: 23382263
[TBL] [Abstract][Full Text] [Related]
3. Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism.
Småbrekke B; Rinde LB; Evensen LH; Morelli VM; Hveem K; Gabrielsen ME; Njølstad I; Mathiesen EB; Rosendaal FR; Braekkan SK; Hansen JB
J Thromb Haemost; 2019 Aug; 17(8):1363-1371. PubMed ID: 31124268
[TBL] [Abstract][Full Text] [Related]
4. Association of venous thromboembolism and myocardial infarction with Factor V Leiden and Factor II gene mutations among Libyan patients.
Msalati A; Bashein A; Ghrew M; Khalil I; Sedaa K; Ali A; Zaid A
Libyan J Med; 2021 Dec; 16(1):1857525. PubMed ID: 33470184
[TBL] [Abstract][Full Text] [Related]
5. A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q.
Heit JA; Armasu SM; Asmann YW; Cunningham JM; Matsumoto ME; Petterson TM; De Andrade M
J Thromb Haemost; 2012 Aug; 10(8):1521-31. PubMed ID: 22672568
[TBL] [Abstract][Full Text] [Related]
6. Do heterozygous factor V Leiden and prothrombin G20210A mutations have different impact on the type and location of venous thromboembolism?
Chevalier Y; Mandrillon G; Bestion A; Lega JC; Piquet P; Ninet J; Dargaud Y
Int Angiol; 2014 Aug; 33(4):404-5. PubMed ID: 25056173
[No Abstract] [Full Text] [Related]
7. Interaction between blood type, smoking and factor V Leiden mutation and risk of venous thromboembolism: a Danish case-cohort study.
El-Galaly TC; Kristensen SR; Overvad K; Steffensen R; Tjønneland A; Severinsen MT
J Thromb Haemost; 2012 Oct; 10(10):2191-3. PubMed ID: 22577971
[No Abstract] [Full Text] [Related]
8. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
[TBL] [Abstract][Full Text] [Related]
9. Classic thrombophilic gene variants.
Mannucci PM; Franchini M
Thromb Haemost; 2015 Nov; 114(5):885-9. PubMed ID: 26018405
[TBL] [Abstract][Full Text] [Related]
10. The distribution of Factor V Leiden mutation.
Eroğlu A
J Thromb Thrombolysis; 2013 Oct; 36(3):341-2. PubMed ID: 23184485
[No Abstract] [Full Text] [Related]
11. Evaluation of ABO blood groups as a risk factor for myocardial infarction.
Jukic I; Bingulac-Popovic J; Dogic V; Hecimovic A; Babic I; Batarilo I; Maglov C; Sturm D
Blood Transfus; 2013 Jul; 11(3):464-5. PubMed ID: 23149138
[No Abstract] [Full Text] [Related]
12. Genotype of proband and thrombophilia screening.
Sandset PM
Blood; 2013 Oct; 122(15):2528-9. PubMed ID: 24113791
[No Abstract] [Full Text] [Related]
13. Clinical characteristics of patients with factor V Leiden or prothrombin G20210A and a first episode of venous thromboembolism. Findings from the RIETE Registry.
Gadelha T; Roldán V; Lecumberri R; Trujillo-Santos J; del Campo R; Poggio R; Monreal M;
Thromb Res; 2010 Oct; 126(4):283-6. PubMed ID: 20627204
[TBL] [Abstract][Full Text] [Related]
14. Multilocus genetic risk scores for venous thromboembolism risk assessment.
Soria JM; Morange PE; Vila J; Souto JC; Moyano M; Trégouët DA; Mateo J; Saut N; Salas E; Elosua R
J Am Heart Assoc; 2014 Oct; 3(5):e001060. PubMed ID: 25341889
[TBL] [Abstract][Full Text] [Related]
15. Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups.
Rios DR; Fernandes AP; Carvalho MG; Figueiredo RC; Guimarães DA; Reis DR; Simões e Silva AC; Gomes KB; Dusse LM
Clin Chim Acta; 2011 Feb; 412(5-6):425-9. PubMed ID: 21070754
[TBL] [Abstract][Full Text] [Related]
16. Is there a significant lower genetic susceptibility to venous thrombosis in the Basques?
Bauduer F
Blood Coagul Fibrinolysis; 2014 Sep; 25(6):645-7. PubMed ID: 25083731
[No Abstract] [Full Text] [Related]
17. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.
Simone B; De Stefano V; Leoncini E; Zacho J; Martinelli I; Emmerich J; Rossi E; Folsom AR; Almawi WY; Scarabin PY; den Heijer M; Cushman M; Penco S; Vaya A; Angchaisuksiri P; Okumus G; Gemmati D; Cima S; Akar N; Oguzulgen KI; Ducros V; Lichy C; Fernandez-Miranda C; Szczeklik A; Nieto JA; Torres JD; Le Cam-Duchez V; Ivanov P; Cantu-Brito C; Shmeleva VM; Stegnar M; Ogunyemi D; Eid SS; Nicolotti N; De Feo E; Ricciardi W; Boccia S
Eur J Epidemiol; 2013 Aug; 28(8):621-47. PubMed ID: 23900608
[TBL] [Abstract][Full Text] [Related]
18. Is Turkey a prothrombin gene mutation region similar to the Mediterranean countries?
Buğan B; Yıldırım E; Torun D; Kozan S; Çelik M; Çelik T
Anatol J Cardiol; 2016 Mar; 16(3):228. PubMed ID: 27067577
[No Abstract] [Full Text] [Related]
19. Do Factor V Leiden and Prothrombin G20210A Mutations Predict Recurrent Venous Thromboembolism in Older Patients?
Méan M; Limacher A; Stalder O; Angelillo-Scherrer A; Alberio L; Fontana P; Beer HJ; Rodondi N; Lämmle B; Aujesky D
Am J Med; 2017 Oct; 130(10):1220.e17-1220.e22. PubMed ID: 28606797
[TBL] [Abstract][Full Text] [Related]
20. Influence of proband's characteristics on the risk for venous thromboembolism in relatives with factor V Leiden or prothrombin G20210A polymorphisms.
Bucciarelli P; De Stefano V; Passamonti SM; Tormene D; Legnani C; Rossi E; Castaman G; Simioni P; Cini M; Martinelli I
Blood; 2013 Oct; 122(15):2555-61. PubMed ID: 23913469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
